Division of Cancer Epidemiology and Genetics, National Cancer Institute,NIH/DHHS, Bethesda, MD, USA.
Int J Hematol. 2013 Jun;97(6):793-9. doi: 10.1007/s12185-013-1345-5. Epub 2013 May 3.
Genetic variation in immune-related genes, such as IL10 and TNF, have been associated with the development of non-Hodgkin lymphoma (NHL) in Caucasian populations. To test the hypothesis that IL10 and TNF polymorphisms may be associated with NHL risk in Asian populations, we genotyped 20 single nucleotide polymorphisms (SNPs) within the IL10 and TNF/LTA loci in three independent case-control studies (2635 cases and 4234 controls). IL10 rs1800871, rs1800872, and rs1800896 were genotyped in all three studies, while 5 of the remaining SNPs were genotyped in two studies, and 12 in a single study. IL10 rs1800896 was associated with B cell lymphoma [per-allele odds ratio (OR) = 1.25, 95 % confidence interval (CI) 1.08-1.45; p trend = 0.003], specifically diffuse large B cell lymphoma (DLBCL) (per-allele OR = 1.29, 95 % CI 1.08-1.53; p trend = 0.004), as well as T cell lymphoma (per-allele OR = 1.44, 95 % CI 1.13-1.82; p trend = 0.003). TNF rs1800629, which was genotyped in only two of our studies, was also associated with B cell lymphoma (per-allele OR = 0.77, 95 % CI 0.64-0.91; p trend = 0.003), specifically DLBCL (per-allele OR = 0.69, 95 % CI 0.55-0.86; p trend = 0.001). Our findings suggest that genetic variation in IL10 and TNF may also play a role in lymphomagenesis in Asian populations.
免疫相关基因(如 IL10 和 TNF)的遗传变异与白种人群中非霍奇金淋巴瘤(NHL)的发展有关。为了检验假设,即 IL10 和 TNF 多态性可能与亚洲人群中的 NHL 风险相关,我们在三个独立的病例对照研究(2635 例病例和 4234 例对照)中对 IL10 和 TNF/LTA 基因座内的 20 个单核苷酸多态性(SNP)进行了基因分型。在所有三个研究中均对 IL10 rs1800871、rs1800872 和 rs1800896 进行了基因分型,而其余 5 个 SNP 在两个研究中进行了基因分型,12 个 SNP 在一个研究中进行了基因分型。IL10 rs1800896 与 B 细胞淋巴瘤相关(每个等位基因的优势比(OR)= 1.25,95%置信区间(CI)为 1.08-1.45;p 趋势= 0.003),特别是弥漫性大 B 细胞淋巴瘤(DLBCL)(每个等位基因的 OR = 1.29,95%CI 为 1.08-1.53;p 趋势= 0.004),以及 T 细胞淋巴瘤(每个等位基因的 OR = 1.44,95%CI 为 1.13-1.82;p 趋势= 0.003)。仅在我们的两项研究中进行基因分型的 TNF rs1800629 也与 B 细胞淋巴瘤相关(每个等位基因的 OR = 0.77,95%CI 为 0.64-0.91;p 趋势= 0.003),特别是 DLBCL(每个等位基因的 OR = 0.69,95%CI 为 0.55-0.86;p 趋势= 0.001)。我们的研究结果表明,IL10 和 TNF 中的遗传变异也可能在亚洲人群的淋巴瘤发生中起作用。